S100B protein in neurodegenerative disorders (Q37837904)

24 August 2017

1 reference

title

S100B protein in neurodegenerative disorders (English)

1 reference

24 August 2017

1 reference

Matthias L. Schroeter

series ordinal

3

object named as

Matthias L Schroeter

1 reference

24 August 2017

Johann Steiner

1

1 reference

24 August 2017

Bernhard Bogerts

series ordinal

2

1 reference

24 August 2017

Hans-Gert Bernstein

series ordinal

4

1 reference

24 August 2017

publication date

9 February 2011

1 reference

Clinical Chemistry and Laboratory Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

49

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

409-424

1 reference

A soluble protein characteristic of the nervous system

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

An update of the S100 nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B's double life: intracellular regulator and extracellular signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Evidence for a wide extra-astrocytic distribution of S100B in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Identification of an S100A1/S100B target protein: phosphoglucomutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Dynamics of brain-derived proteins in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Oligodendrocytes as providers of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B in neuropathologic states: the CRP of the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Secretion of S-100 from rat C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Active secretion of S100B from astrocytes during metabolic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B binding to RAGE in microglia stimulates COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100b counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Spatial and nonspatial learning in mice: effects of S100 beta overexpression and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Glial protein S100B modulates long-term neuronal synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100B in brain damage and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

beta-Amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Studies of neuroimmune markers in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Machado-Joseph disease: an autosomal dominant motor system degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Course and long-term treatment of schizophrenic psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Regional brain volume change over the life-time course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

The reduced neuropil hypothesis: a circuit based model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

The role of oligodendrocyte pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Neuroimaging and neurobiological models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Magnetic-resonance morphometry in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Gliogenesis and glial pathology in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Serum markers support disease-specific glial pathology in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Haloperidol and clozapine decrease S100B release from glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

No association of the rs9722 C >T in the S100B gene and susceptibility to major depression in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Serum S100B protein is increased in fasting rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Relationship between stress and circulating levels of S100B protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

S100A1 and S100B expression and target proteins in type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Isolation of a rat S100α cDNA and distribution of its mRNA in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Brain abnormalities in human obesity: a voxel-based morphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Guidelines for the next 10 years of proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

REporting recommendations for tumour MARKer prognostic studies (REMARK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.083

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.083

1 reference

24 August 2017

1 reference